Castle Biosciences, Inc. (CSTL)
29.21
-2.13
(-6.80%)
USD |
NASDAQ |
Feb 20, 16:00
29.03
-0.18
(-0.62%)
Pre-Market: 20:00
Castle Biosciences SG&A Expense (Quarterly) : 55.91M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 76.66M |
| Delcath Systems, Inc. | 10.34M |
| CorMedix, Inc. | 36.64M |
| CytoSorbents Corp. | 8.61M |
| Odyssey Health, Inc. | 0.3032M |